hepatocellular carcinoma

Use of MDS Nordion 's TheraSphere in Hepatocellular Carcinoma Patients Subject of Several Physicians' Presentations MDS Nordion , a global leader in providing products and services for medical imaging ...
Wednesday, 17 March 2010
... hepatitis C and hepatocellular carcinoma (HCC) and 77 matched controls without cancer starting a year before diagnosis up to diagnosis. Using a cutoff of 40 mAU/mL for DCP, the researchers found that ...
Thursday, 25 February 2010
... cost saving." Non-alcoholic fatty liver disease has become more common as the incidence of metabolic syndrome and obesity has grown. The condition can progress to cirrhosis and hepatocellular carcinoma, ...
Saturday, 30 January 2010
4. Familiarize with the Cyberknife
(Radiology News/Radiology Articles)
... radiation equipment. SBRT can now be offered as a viable alternative to surgery in the following clinical situations: Primary Liver Cancer (Hepatocellular carcinoma or HCC) Lung Cancer ...
Thursday, 19 March 2009
Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer worldwide, and its incidence is constantly increasing.1,2 There are 13,000?19,000 cases per year in the US and 350,000 to one million ...
Saturday, 29 November 2008
... progress to cirrhosis, liver failure, and hepatocellular carcinoma, especially in patients with more advanced fibrosis. Liver biopsy is currently the only reliable way to determine the severity of fibrosis. ...
Tuesday, 30 November 1999
... nearly ten per cent of China's population is at high risk for hepatocellular carcinoma (HCC), a liver cancer with low survival rates if not detected and treated early. Researchers report on a new blood ...
Tuesday, 30 November 1999
A novel mass-spectrometry based form of proteomic profiling is more accurate than traditional biomarkers in distinguishing liver cancer patients from those with hepatitis C liver cirrhosis, a study shows. As ...
Tuesday, 30 November 1999
... was formed in 2004 to develop new techniques for liver imaging. Among his goals are to optimize clinical MR imaging protocols for hepatocellular carcinoma, the most common form of liver tumor; improved ...
Tuesday, 30 November 1999
Percutaneous imaging guided radiofrequency ablation (RFA) of hepatocellular carcinoma is a safe and effective technique, with benefits such as reduced post-procedural pain and length of hospital stay. ...
Tuesday, 30 November 1999
New methodology developed by scientists at the Chinese University of Hong Kong can detect and quantify serum levels of a hypermethylated tumor suppressor gene associated with hepatocellular carcinoma (HCC). Dr. ...
Tuesday, 30 November 1999
Surveillance for the early diagnosis of hepatocellular carcinoma (HCC) in cirrhosis patients appears to be useful only for those in earlier stages of the disease. Italian researchers report in the ...
Tuesday, 30 November 1999
Radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC) is as effective when delivered percutaneously as with a surgical approach, but with lower morbidity, according to a report in the December ...
Tuesday, 30 November 1999
... additional laboratory and preclinical research, Schmittgen says. Liver cancer, or hepatocellular carcinoma, is the third most common cause of cancer death worldwide, killing some 662,000 people in 2005, ...
Tuesday, 30 November 1999
... exciting aspect of our findings," senior investigator Dr. Nezham H. Afdhal told Reuters Health, "is that SELDI-TOF-MS was better able to detect small early hepatocellular carcinoma compared to other routine ...
Tuesday, 30 November 1999
Radiofrequency ablation combined with chemoembolization provides comparable overall and disease-free survival as hepatectomy for early-stage hepatocellular carcinoma, Japanese investigators report.  ...
Tuesday, 30 November 1999
... that may improve long-term survival for patients with hepatocellular carcinoma [liver cancer] larger than 3 cm," the authors conclude. JAMA 2008;299[14]:1669-1677 Editorial: Expanding the treatment ...
Tuesday, 30 November 1999
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report. "Patients with this ...
Tuesday, 30 November 1999
Patients with metastatic hepatocellular carcinoma (HCC) who receive multipolar radiofrequency ablation have very high tumor eradication rates. They also have survival rates similar to patients who ...
Tuesday, 30 November 1999
... Viral cancers include cervical cancers caused by infection with a human papillomavirus (HPV), a sexually transmitted disease; hepatocellular carcinoma (HCC), a cancer of the liver; various lymphomas and ...
Tuesday, 30 November 1999
<< Start < Prev 1 2 Next > End >>
Page 1 of 2
Follow us on...
Facebook Page: 174226168059 Linked In Group: 2434026 Twitter: medicexchange